Published in Genetics and Environmental Business Week, February 24th, 2005
At Silicon Genetics, where Bates was most recently CFO, he helped negotiate the sale of the company to Agilent Technologies. Prior to Silicon Genetics, he was CFO at Penederm and Collagen Aesthetics, respectively.
Bates' background includes experience with both public and private companies.
SFMT's first product, the X STOP Interspinous Process Decompression (IPD) System for treatment of lumbar spinal stenosis, provides a minimally invasive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.